NFATC2 and melanoma: By whole-genome gene expression analysis of a melanoma transfectant (Me71) with stable knockdown of NFATc2 (NFATc2_shRNA_86a) we observed reduced expression of Myc, FOXM1, and EZH2 compared to two different control transfectants (column entitled “Log ratio” in Supplementary Table S2a,b).